Press Releases

Date Title and Summary Additional Formats
Toggle Summary Biocept to Present at the LD Micro 500 Virtual Conference
SAN DIEGO , Aug. 27, 2020 /PRNewswire/ --  Biocept, Inc . (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients, announces that President and CEO Michael Nall will present at the
View HTML
Toggle Summary Biocept Names Michael Dugan, M.D. Chief Medical Officer and Medical Director
SAN DIEGO , Aug. 24, 2020 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients, announces the appointment of Michael C. Dugan , M.D.
View HTML
Toggle Summary Biocept to Present at the Proactive One2One Virtual Investor Forum on August 25
SAN DIEGO , Aug. 20, 2020 (GLOBE NEWSWIRE) -- Biocept, Inc . (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients, announces that President and CEO Michael Nall will present at
View HTML
Toggle Summary Biocept Expands Agreement with MultiPlan to Include COVID-19 Testing
SAN DIEGO , Aug. 19, 2020 (GLOBE NEWSWIRE) -- Biocept, Inc . (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients, announces the expansion of its agreement with MultiPlan,
View HTML
Toggle Summary Biocept Awarded US Patent for proprietary Primer-Switch Mutation Detection and Amplification Improvement Platform Used to Detect Rare Cell Mutations, Including Cancer Biomarkers
Expands Company's patent portfolio and marks another step in pursuit of worldwide intellectual property protection for proprietary Primer-Switch technology used to detect rare events such as cancer biomarkers found in tissue and liquid biopsies SAN DIEGO , Aug.
View HTML
Toggle Summary Biocept Announces Agreement with Healthcare Group to Provide COVID-19 Testing to Multi-State Locations
Healthcare Group supports more than 50 skilled nursing facilities SAN DIEGO , Aug. 13, 2020 /PRNewswire/ --  Biocept, Inc . (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve outcomes, announces it
View HTML
Toggle Summary Biocept Reports Second Quarter 2020 Financial Results
Conference call begins at 4:30 p.m. Eastern time today SAN DIEGO , Aug. 12, 2020 /PRNewswire/ --  Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients, reports financial
View HTML
Toggle Summary Biocept Announces Agreement with Aegea Biotechnologies to Develop New, Highly Sensitive PCR-based COVID-19 Assay Utilizing Patented Switch-Blocker PCR Technology
Collaboration highlights the power and versatility of the proprietary Switch-Blocker technology, which may be applied to molecular diagnostics in COVID-19 and other infectious diseases, in addition to oncology applications currently commercialized and in development SAN DIEGO , Aug.
View HTML
Toggle Summary Biocept to Release Second Quarter 2020 Financial Results and Host Investor Conference Call on August 12, 2020
SAN DIEGO , Aug. 4, 2020 /PRNewswire/ --  Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial
View HTML
Toggle Summary Biocept Reaches COVID-19 Testing Milestone with More than 7,000 Specimens Received and More than 6,500 Specimens Processed
Announces distribution of nearly 12,000 specimen collection kits to clients and has current availability of approximately 18,000 kits for immediate distribution   Expects Company-developed collection kits to be available later this quarter SAN DIEGO , Aug. 3, 2020 /PRNewswire/ --  Biocept, Inc .
View HTML